Investor
The company’s platform, OncoGaze, analyzes genomic biomarkers from routine clinical slides to help clinicians select personalized therapies.
The company will use the funds to expand its clinical agent platform and grow its partnerships with care organizations.
The funds will be used to expand access to its AI therapist assistant Sage that provides 24/7 clinically supervised mental health support to patients between therapy sessions.
The company will use the funds to expand its presence globally and enhance its platform.
The company will use the funds to expand its agentic AI platform and fund new models for employers, including access to GLP-1 medications.
AI revenue cycle management platform Adonis raises $40 million and Blossom Health, a telehealth platform for psychiatry, garners $20 million.
The Series B marks the company's third funding round in less than a year.
The company will use the funds to enhance its platform, grow its workforce and expand partnerships with health systems to automate medication approval workflows.
The company will use the funds to accelerate development of its AI precision health platform.
The company will use the funds to scale its platform, hire engineers and data scientists, deepen clinical integrations and speed the deployment of custom AI agents.